{"id":"treatment-with-oral-sucrosomial-iron","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbance (nausea, constipation, abdominal discomfort)"},{"rate":null,"effect":"Dark stools"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL319156","moleculeType":"Small molecule","molecularWeight":"498.32"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sucrosomial iron encapsulates ferric iron within a proprietary sucrose-based lipid matrix that protects the iron from gastric acid and facilitates absorption in the small intestine. This formulation technology improves iron bioavailability compared to conventional iron salts while minimizing direct contact between iron and the intestinal mucosa, thereby reducing common gastrointestinal adverse effects associated with oral iron supplementation.","oneSentence":"Sucrosomial iron delivers iron in a lipid-based carrier that enhances intestinal absorption and bioavailability while reducing gastrointestinal irritation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:14:14.552Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia"}]},"trialDetails":[{"nctId":"NCT07287371","phase":"PHASE4","title":"Sucrosomial Vs Intravenous Iron for Preoperative Anemia","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2025-12-31","conditions":"Anemia, Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT03833336","phase":"PHASE3","title":"Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)","status":"COMPLETED","sponsor":"Institut de Recerca Biomèdica de Lleida","startDate":"2017-08-23","conditions":"Heart Failure With Normal Ejection Fraction, Ferropenic Anemia","enrollment":72},{"nctId":"NCT05225545","phase":"PHASE3","title":"Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2019-11-04","conditions":"Anemia, Iron Deficiency, Ulcerative Colitis","enrollment":30},{"nctId":"NCT05702970","phase":"PHASE4","title":"Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2024-01-15","conditions":"Heart Failure, Iron-deficiency, Heart Failure, Systolic","enrollment":258},{"nctId":"NCT02916654","phase":"NA","title":"Sucrosomial Iron in Patients With Celiac Disease and IDA","status":"UNKNOWN","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2015-04","conditions":"Celiac Disease, Iron Deficiency Anemia","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Treatment with oral sucrosomial iron","genericName":"Treatment with oral sucrosomial iron","companyName":"University of Rochester","companyId":"university-of-rochester","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sucrosomial iron delivers iron in a lipid-based carrier that enhances intestinal absorption and bioavailability while reducing gastrointestinal irritation. Used for Iron deficiency anemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}